YubNub Social YubNub Social
    #humor #history #ai #artificialintelligence #automotiveengineering
    Advanced Search
  • Login
  • Register

  • Day mode
  • © 2025 YubNub Social
    About • Directory • Contact Us • Developers • Privacy Policy • Terms of Use • shareasale • FB Webview Detected • Android • Apple iOS • Get Our App

    Select Language

  • English
Install our *FREE* WEB APP! (PWA)
Night mode toggle
Community
News Feed (Home) Popular Posts Events Blog Market Forum
Media
Go LIVE! Headline News VidWatch Game Zone Top PodCasts
Explore
Explore Offers
© 2025 YubNub Social
  • English
About • Directory • Contact Us • Developers • Privacy Policy • Terms of Use • shareasale • FB Webview Detected • Android • Apple iOS • Get Our App
Advertisement
Stop Seeing These Ads

Discover posts

Posts

Users

Pages

Group

Blog

Market

Events

Games

Forum

Conservative Voices
Conservative Voices
1 w Politics

rumbleRumble
The Will Cain Show (Full episode) - Friday, June 27
Like
Comment
Share
Fun Facts And Interesting Bits
Fun Facts And Interesting Bits
1 w ·Youtube General Interest

YouTube
This Planet Wondering Through the Galaxy Could Bring Trouble
Like
Comment
Share
100 Percent Fed Up Feed
100 Percent Fed Up Feed
1 w

CDC Vaccine Advisory Panel Recommends Merck’s RSV Shot For Infants Despite Safety Concerns
Favicon 
100percentfedup.com

CDC Vaccine Advisory Panel Recommends Merck’s RSV Shot For Infants Despite Safety Concerns

In a controversial decision, the Advisory Committee on Immunization Practices (ACIP) voted on Thursday to recommend Merck’s monoclonal antibody shot against respiratory syncytial virus (RSV) for infants up to one year of age. The panel, which advises the Centers for Disease Control and Prevention (CDC) on the vaccine schedule, held its first meeting since Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. retired prior members. HHS Secretary Robert F. Kennedy Jr. Appoints Robert Malone, Others To Vaccine Advisory Panel The committee voted 5-2 to recommend the use of Merck's shot. RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants https://t.co/7yBvsv64tX — CNBC (@CNBC) June 26, 2025 CNN shared additional details: The advisers also voted 5-2 on Thursday to recommend the use of a new shot that can protect babies from respiratory syncytial virus, adding an additional tool against the most common cause of hospitalization in infants. The shot, called clesrovimab and given the brand name Enflonsia, is made by Merck and joins two other interventions already on the market to protect babies against severe disease from RSV, a common virus that can be especially dangerous for infants. One, like clesrovimab, is an antibody shot, and the other is a vaccine given during pregnancy. Data presented at the meeting showed that the approved interventions were safe and dramatically reduced hospitalizations among babies from RSV in the last respiratory virus season. “As a pediatrician, I mean, people need to understand what a spectacular accomplishment these results are,” Meissner said at Wednesday’s ACIP meeting. They “will have an enormous influence on public health.” The new drug was approved this month by the FDA, and the CDC committee’s recommendation was the next step in making it widely available for the coming RSV season, which typically begins in the fall. As 100 Percent Fed Up highlighted earlier this month, the FDA approved Merck's RSV shot despite a disturbing serious adverse event rate in clinical trials. FDA Approves RSV Shot For Infants – DISTURBING Serious Adverse Event Rate In Clinical Trials “ENFLONSIA is a preventive, long-acting monoclonal antibody (mAb) designed to provide direct, rapid and durable protection through 5 months, a typical RSV season, with the same 105 mg dose regardless of weight,” Merck stated. Children’s Health Defense warned the monoclonal antibody shot had a staggering 11.71% serious adverse event rate. “These included febrile convulsions, seizures, facial paralysis and brain injury at about three times the rate in the vaccine group (25 of 2,409) as the placebo group (4 of 1,202),” Children’s Health Defense wrote. ? FDA Greenlights Merck’s RSV Shot for Newborns — Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death The clinical trial results posted on the government website https://t.co/HgDdO4C6Qc included serious neurological adverse reactions that Dr. Peter… pic.twitter.com/jQAQfyTuyH — Children’s Health Defense (@ChildrensHD) June 11, 2025 Full text: FDA Greenlights Merck’s RSV Shot for Newborns — Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death The clinical trial results posted on the government website http://ClinicalTrials.gov included serious neurological adverse reactions that Dr. Peter Selley, a U.K. general practitioner who has closely followed the development of the drugs for RSV, called “concerning.” These included febrile convulsions, seizures, facial paralysis and brain injury at about three times the rate in the vaccine group (25 of 2,409) as the placebo group (4 of 1,202). Children’s Health Defense Senior Research Scientist Karl Jablonowski said the trials showed a serious adverse event rate of 11.71% and included: A 50% greater chance of death (three deaths in the group that received the shot versus one in the placebo group). A 350% greater chance of an upper respiratory tract infection. A 63% greater chance of a lower respiratory tract infection. A 41% greater chance of febrile convulsion. According to Children's Health Defense, several concerns about possible adverse event signals were raised during the ACIP meeting. "Yesterday's vote on @Merck's new monoclonal antibody shot came after Retsef Levi, Ph.D. (@RetsefL) raised several concerns about possible adverse event signals from the drug’s clinical trials. In one trial, he said, there were five deaths in the vaccinated baby group and none in the placebo group. In another, when compared with an existing treatment, the death ratio was 5-to-1. In a third trial, it was 7-to-3," Children's Health Defense wrote. "In one of the trials, immunized babies admitted to the hospital for RSV-related illness stayed longer than non-immunized babies with the same condition. Levi said this raises concerns that the immunization may have worsened their illness — a phenomenon called immunization-enhanced disease, which has complicated previous attempts to develop an RSV vaccine for infants," it continued. "He said the trials and the adverse events were small, but 'should we perhaps be concerned?' Two of the seven committee members, Retsef Levi, Ph.D., and Vicky Pebsworth, Ph.D., opposed the recommendation, citing safety concerns. The remaining five members supported it," it added. New CDC Vaccine Panel Recommends Merck’s RSV Shot for All Newborns Yesterday's vote on @Merck's new monoclonal antibody shot came after Retsef Levi, Ph.D. (@RetsefL) raised several concerns about possible adverse event signals from the drug’s clinical trials. In one trial, he… pic.twitter.com/yGg7BCVcdW — Children’s Health Defense (@ChildrensHD) June 27, 2025 More from The Defender: A Merck representative said investigators conducted an extensive analysis of the adverse events and determined none were related to the shot. She also noted that the FDA review was extensive and that the agency ultimately approved the shot. Dr. Meryl Nass, who live-blogged the meeting for Children’s Health Defense (CHD) on CHD.TV, wrote, “I have to say this is what is always claimed by the manufacturer and the CDC, usually with no supportive information.” A researcher from the FDA acknowledged Levi’s point, saying “numerical numbers go in the wrong direction,” but the percentage differences were very small, between 0.2% and 0.3%, she said. Co-chair Martin Kulldorff, Ph.D., said it would be critically important to monitor adverse events going forward. New committee member Dr. H. Cody Meissner, who was part of the RSV work group, strongly supported the approval. He said the group had extensively discussed Levi’s concerns and was comfortable with the clinical trial results. CHD Senior Research Scientist Karl Jablonowski told The Defender that despite Meissner’s assurances, the CDC working group noted that they “have serious concerns in the certainty assessment, specifically imprecision because ‘too few infants were included in the trial to capture rare events.’” Jablonowski said that the trials showed clear risks and the drug “clearly needs a larger clinical trial to assess the risk to the most vulnerable. However, because the drug was approved, it won’t be a clinical trial of a few thousand that shows the risk; it will be population-wide surveillance.” New committee member and ACIP co-chair Dr. Robert Malone also voiced strong support for the shots. Despite the short time frame, he said the group had conducted a rigorous analysis. Levi, a father of six, said if he had a high-risk child, he would use the product to protect them. “On the other hand, if I was the father — and luckily I was the father — of a healthy child that was born on time, knowing all of this, I would be concerned to use it.” After the vote to recommend Merck’s shot, all seven members then voted to add it to the Vaccines for Children Program, making it available for free to all infants whose families cannot afford it. The program serves more than 50% of U.S. children.
Like
Comment
Share
Classic Rock Lovers
Classic Rock Lovers  
1 w

"We refused to believe we didn't have something special." From triumph to tragedy and triumph again, how Linkin Park became the first true metal breakout of the 21st century
Favicon 
www.loudersound.com

"We refused to believe we didn't have something special." From triumph to tragedy and triumph again, how Linkin Park became the first true metal breakout of the 21st century

Linkin Park are among the most successful and influential bands the entire nu metal movement ever produced
Like
Comment
Share
Fun Facts And Interesting Bits
Fun Facts And Interesting Bits
1 w

10 Warning Labels That Exist Because Someone Actually Tried It
Favicon 
listverse.com

10 Warning Labels That Exist Because Someone Actually Tried It

We’ve all seen ridiculous warning labels that seem to insult our intelligence, like “Do not eat” printed on silica gel packets, or “remove child before folding” on a stroller. But as absurd as these may sound, every one of them exists because someone, somewhere, actually did the thing they were told not to. Behind each […] The post 10 Warning Labels That Exist Because Someone Actually Tried It appeared first on Listverse.
Like
Comment
Share
Conservative Voices
Conservative Voices
1 w

Kristi Noem: This is the 'future' of immigration enforcement
Favicon 
www.brighteon.com

Kristi Noem: This is the 'future' of immigration enforcement

Follow NewsClips channel at Brighteon.com for more updatesSubscribe to Brighteon newsletter to get the latest news and more featured videos: https://support.brighteon.com/Subscribe.html
Like
Comment
Share
Conservative Voices
Conservative Voices
1 w

Jesse Watters: Trump’s best week ever just got even better
Favicon 
www.brighteon.com

Jesse Watters: Trump’s best week ever just got even better

Follow NewsClips channel at Brighteon.com for more updatesSubscribe to Brighteon newsletter to get the latest news and more featured videos: https://support.brighteon.com/Subscribe.html
Like
Comment
Share
Conservative Voices
Conservative Voices
1 w

TRUMP ON TOP: Major win could reshape presidential power for generations
Favicon 
www.brighteon.com

TRUMP ON TOP: Major win could reshape presidential power for generations

Follow NewsClips channel at Brighteon.com for more updatesSubscribe to Brighteon newsletter to get the latest news and more featured videos: https://support.brighteon.com/Subscribe.html
Like
Comment
Share
Conservative Voices
Conservative Voices
1 w

Gutfeld!': Dems' podcast problems
Favicon 
www.brighteon.com

Gutfeld!': Dems' podcast problems

Follow NewsClips channel at Brighteon.com for more updatesSubscribe to Brighteon newsletter to get the latest news and more featured videos: https://support.brighteon.com/Subscribe.html
Like
Comment
Share
Intel Uncensored
Intel Uncensored
1 w

G. Edward Griffin- UN AGENDA 21- No property rights, No Individual rights, No freedom, Depopulation
Favicon 
api.bitchute.com

G. Edward Griffin- UN AGENDA 21- No property rights, No Individual rights, No freedom, Depopulation

UN AGENDA 21 No property rights No Individual rights No freedom Universal income Depopulation Every aspect of life will be controlled for sustainable development G. Edward Griffin
Like
Comment
Share
Showing 1001 out of 84517
  • 997
  • 998
  • 999
  • 1000
  • 1001
  • 1002
  • 1003
  • 1004
  • 1005
  • 1006
  • 1007
  • 1008
  • 1009
  • 1010
  • 1011
  • 1012
  • 1013
  • 1014
  • 1015
  • 1016
Stop Seeing These Ads

Edit Offer

Add tier








Select an image
Delete your tier
Are you sure you want to delete this tier?

Reviews

In order to sell your content and posts, start by creating a few packages. Monetization

Pay By Wallet

Payment Alert

You are about to purchase the items, do you want to proceed?

Request a Refund